Delivery Order SPE2DB22D3501-SPE2DB24FVQ30
- Not listed
- This is a $1,739.24 Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Pfizer COVID-19 vaccines (0.9ml) during the period of June 2023 to April 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation. Amerisourcebergen, as a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a $999,999,999.00 Indefinite Delivery...
- This federal contract award is for a delivery order worth $1,081.34 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Pfizer's COVID-19 vaccine, including 0.9 ML doses, from June 2023 to February 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Pfizer COVID-19 vaccine doses. The $1,081.35 award is for an estimated 0.9 ml doses to be delivered by January 4, 2024. Amerisourcebergen is a prime contractor that has previously supplied pharmaceuticals and medical supplies to DLA Troop Support Medical facilities. This order is not associated with a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $1,227.33, is for the delivery of Pfizer COVID-19 vaccine doses with a 6-month to 4-year shelf life under the Emergency Use Authorization (EUA). The contract does not have a set-aside designation. AmerisourceBergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, a $1,081.34 firm fixed price delivery order, is for the provision of Pfizer COVID-19 vaccine doses in the 6-month to 4-year dosage form under the Emergency Use Authorization (EUA). The contract has a completion date of January 31, 2024. Amerisourcebergen Drug Corp, as the prime...
- This federal contract award, valued at $1,100.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pfizer COVID-19 vaccine doses, with a period of performance from May 2024 to May 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award, valued at $3,244.02, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Pfizer COVID-19 vaccines and related medical supplies, including 0.9 ml dosages, to support the agency's healthcare programs from June 2023 to January 2024. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition....
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,244.02 Firm Fixed Price Delivery Order covers the supply of Pfizer COVID-19 vaccine doses, with an ultimate completion date of January 12, 2024. This contract supports the DLA's efforts to provide medical supplies and vaccines to military treatment facilities and other government healthcare programs. The contract has no set-aside...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of 0.9 ML doses of Pfizer's COVID-19 vaccine for the 2023-2024 period, under an Emergency Use Authorization (EUA). The contract has a firm fixed price of $25,691.25 and a completion date of April 16, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S....
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,162.70 firm fixed price delivery order is for the provision of Pfizer's COVID-19 vaccine over a term from June 2023 to March 2024. This contract is part of a larger DLA indefinite delivery contract (IDC) with Amerisourcebergen Drug Corp, valued at up to...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FVQ30Delivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,525.97 contract is for the delivery of Pfizer COVID-19 vaccine doses over a period of 6 months to 4 years. The contract is a Firm Fixed Price type with no set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with expertise in pharmaceutical distribution and logistics to support the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The parent company, Cencora, Inc., doing business as Amerisourcebergen, also holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 5/10/24 |